News & Events

News

All categories

Earnings

Press Release

All years

2020

2019

2018

2017

2016

2015

2014

Affimed Appoints Dr. Martin Treder as Chief Scientific Officer

January 20, 2015

Affimed Receives EUR 2.4 million ($3 million) Research Grant from German Government to Fund Trispecific Abs

January 7, 2015

Affimed Presents Final Data for AFM13 Phase 1 Trial at ASH

December 8, 2014

Affimed Reports Financial Results for Third Quarter 2014

November 18, 2014

Affimed to Present at the Jefferies Global Healthcare Conference – London

November 12, 2014

Affimed Announces Third Quarter 2014 Financial Results Conference Call

November 11, 2014

Affimed Announces Closing of Initial Public Offering

September 17, 2014

Affimed Announces Pricing of Initial Public Offering

September 12, 2014

Affimed Secures $29.7M in Private Financing from Current and New Investors

September 2, 2014

Ferdinand Verdonck Elected to Affimed’s Supervisory Board

July 25, 2014

Events

All

Scientific

Investors

29May

ASCO 2020 Annual Meeting

May 29 - June 2, 2020 (TBD)

25Aug

Innate Killer Summit 2020

August 25 - July 26, 2020 (San Diego, USA)
Presenter: Joachim Koch

Webcasts
More events

We use cookies to give you the best experience on our website. By continuing to use it, you agree with it.